Capricor Therapeutics
CAPR
#8016
Rank
A$0.43 B
Marketcap
A$9.41
Share price
-4.36%
Change (1 day)
-57.98%
Change (1 year)

Earnings for Capricor Therapeutics (CAPR)

Earnings in 2025 (TTM): -A$0.13 Billion

According to Capricor Therapeutics 's latest financial reports the company's current earnings are A$11.13 Million. In 2024 the company made an earning of -A$59.86 Million a decrease over its 2023 earnings that were of -A$32.97 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Capricor Therapeutics from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.13 Billion112.32%
2024 -A$59.86 Million81.57%
2023 -A$32.97 Million-23.2%
2022 -A$42.92 Million44.93%
2021 -A$29.62 Million46.61%
2020 -A$20.2 Million78.71%
2019 -A$11.31 Million-49.7%
2018 -A$22.47 Million-724.78%
2017 A$3.59 M-112.93%
2016 -A$27.82 Million46.27%
2015 -A$19.02 Million106.82%
2014 -A$9.2 Million-48.41%
2013 -A$17.83 Million977.23%
2012 -A$1.66 Million-77.11%
2011 -A$7.23 Million-22.35%
2010 -A$9.31 Million-20.17%
2009 -A$11.67 Million-41.17%
2008 -A$19.82 Million41.05%
2007 -A$14.06 Million1098.87%
2006 -A$1.18 Million4101.55%
2005 -A$0.03 Million-0.97%
2004 -A$0.03 Million17.87%
2003 -A$0.03 Million3.66%
2002 -A$0.03 Million-30.11%
2001 -A$0.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Cytokinetics
CYTK
-A$1.12 Billion 817.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-A$7.1 Million-94.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$47.91 B-39,612.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$0.86 B-811.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.38 Billion 212.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-A$14.04 Million-88.43%๐Ÿ‡บ๐Ÿ‡ธ USA